Clinical trial failure gives investors hope of a change in strategy
Botox maker Allergan offers a prime example: the company announced Wednesday that its depression drug candidate rapastinel had failed in late stage
clinical trials. Of course, pipeline failures usually are bad news for investors. Yet Allergan shares shot up nearly 4% Thursday and rose again on Friday.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opinion | Trump’s love may be why he’s maintained a strong grasp on his baseOpinion: Trump’s CPAC speech was full of love. It’s been a successful formula for him.
Read more »
Why The Just-Released February Jobs Numbers Are Disappointing -- And Why That MattersThe much-anticipated February Employment Situation Report was released today, showing only 20,000 jobs added. Despite this, unemployment fell to 3.8%. However, this has done little to relieve the concerns of those worried that the expansion may be slowing.
Read more »
Why I am still a Catholic — and why that becomes more difficult every dayWhen the pope and cardinals speak, they do not seem to understand that it feels to us like the Church is disintegrating – and our faith with it.
Read more »
Why U.S. Car Buyers Are Opting For Insane Loans And Why They Should StopU.S. car buyers are over-leveraging themselves with vehicles they can't afford and loans terms that don't make sense. Buying a used vehicle is far smarter for getting the car you want.
Read more »
From meet-cutes to enduring bliss: How co-writers keep the spark aliveBecky Albertalli and Adam Silvera, among other writing partners, explain why two’s company.
Read more »
'Captain Marvel' directors on why they have nothing but love for internet trolls, and how being falsely linked to another Marvel movie might have gotten them the job'Captain Marvel' directors on why they have nothing but love for the internet trolls, and how being falsely linked to another Marvel movie might have gotten them the job
Read more »
Opinion | High time to interview Kelly and many other former Trump officialsOpinion: High time to interview Kelly and many other former Trump officials
Read more »
Opinion | The risk to our economy from secular stagnationAnd why a rethinking of conventional views on macroeconomic policy may be required.
Read more »
36 Unusual Things You Can Actually Spend Money OnYes, really! And honestly, why the heck not?
Read more »